{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:54Z","timestamp":1785300234017,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Robert Koch Institute","award":["1369-339"],"award-info":[{"award-number":["1369-339"]}]},{"name":"Aptalis","award":["IISPYL-EG201309-147"],"award-info":[{"award-number":["IISPYL-EG201309-147"]}]},{"name":"Ministry for Science, Research and Cultural Affairs"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cmi.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:06:33Z","timestamp":1560625593000},"page":"235-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018"],"prefix":"10.1016","volume":"26","author":[{"given":"B.","family":"Bluemel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Loley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Miehlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"T\u00fcffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Usadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vorreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hofreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.-O.","family":"Glocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.06.007_bib1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2019.06.007_bib2","first-page":"167","article-title":"S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease","volume":"55","author":"Fischbach","year":"2017","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.cmi.2019.06.007_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2013the Maastricht V\/florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cmi.2019.06.007_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cmi.2019.06.007_bib5","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/jac\/dku243","article-title":"Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany","volume":"69","author":"W\u00fcppenhorst","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cmi.2019.06.007_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12440","article-title":"High primary antibiotic resistance of Helicobacter pylori strains isolated from dyspeptic patients: a prevalence cross-sectional study in Spain","volume":"22","author":"Mac\u00edas-Garc\u00eda","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.cmi.2019.06.007_bib8","doi-asserted-by":"crossref","first-page":"e12494","DOI":"10.1111\/hel.12494","article-title":"Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing","volume":"23","author":"Bl\u00fcmel","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.cmi.2019.06.007_bib9","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/AAC.49.8.3166-3170.2005","article-title":"Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori","volume":"49","author":"Glocker","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jac\/dkt061","article-title":"High secondary resistance to quinolones in German Helicobacter pylori clinical isolates","volume":"68","author":"Wueppenhorst","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkp003","article-title":"Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany","volume":"63","author":"Wueppenhorst","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-5378.2002.00096.x","article-title":"The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance","volume":"7","author":"Perez-Aldana","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.cmi.2019.06.007_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/MEG.0b013e3283643491","article-title":"Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies","volume":"25","author":"Selgrad","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2019.06.007_bib14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in world health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2019.06.007_bib15","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.3748\/wjg.v20.i29.9912","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance","volume":"20","author":"Smith","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2019.06.007_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.diagmicrobio.2011.05.002","article-title":"Practical use of GenoType\u00ae HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing","volume":"70","author":"Miendje Deyi","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.007_bib17","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dky167","article-title":"Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria","volume":"73","author":"Bachir","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmi.2016.06.003","article-title":"Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods","volume":"22","author":"Ducournau","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.007_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/jmm.0.067942-0","article-title":"Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy","volume":"63","author":"De Francesco","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cmi.2019.06.007_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1523-5378.2007.00506.x","article-title":"Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene","volume":"12","author":"Garrido","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.cmi.2019.06.007_bib21","series-title":"Special Eurobarometer 478, Antimicrobial Resistance Report, 2018","isbn-type":"print","year":"2018","ISBN":"https:\/\/id.crossref.org\/isbn\/9789279967337"},{"key":"10.1016\/j.cmi.2019.06.007_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10620-017-4880-8","article-title":"Helicobacter pylori antimicrobial susceptibility testing-guided salvage therapy in the USA: a real life experience","volume":"63","author":"Tan","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cmi.2019.06.007_bib23","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/jac\/dkv223","article-title":"Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing","volume":"70","author":"Draeger","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jgh.14383","article-title":"Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients","volume":"34","author":"Cho","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2019.06.007_bib25","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/jac\/dkv155","article-title":"Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection","volume":"70","author":"L\u00f3pez-G\u00f3ngora","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.06.007_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cgh.2014.10.036","article-title":"High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection","volume":"13","author":"Yang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2019.06.007_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.06.007_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized non-bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19303143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19303143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:05Z","timestamp":1761117905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19303143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1198743X19303143"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}